The prognostic role of PD-L1 expression in tumor and immune cells in oral cavity squamous cell carcinoma

被引：0
|
作者：
Kutukova, S. [1 ]
Beliak, N. [1 ]
Manikhas, G. [2 ]
Raskin, G. [3 ]
Ivaskova, Y. [4 ]
Popova, N. [1 ]
机构：
[1] City Clin Oncol Dispensary, Chemotherapy Dept, St Petersburg, Russia
[2] City Clin Oncol Dispensary, St Petersburg, Russia
[3] Russian Res Ctr Radiol & Surg Technol, Dept Pathol, St Petersburg, Russia
[4] City Clin Oncol Dispensary, Maxillofacial Surg Dept, St Petersburg, Russia
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1061P
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Clinical and Biological Significance of PD-L1 Expression Within the Tumor Microenvironment of Oral Squamous Cell Carcinoma
    Takahashi, Hideyuki
    Sakakura, Koichi
    Arisaka, Yukiko
    Tokue, Azusa
    Kaira, Kyoichi
    Tada, Hiroe
    Higuchi, Tetsuya
    Okamoto, Ayako
    Tsushima, Yoshito
    Chikamatsu, Kazuaki
    [J]. ANTICANCER RESEARCH, 2019, 39 (06) : 3039 - 3046
  • [32] PROGRAMMED DEATH LIGAND-1 (PD-L1) EXPRESSION STATUS IN PENILE SQUAMOUS CELL CARCINOMA TUMOR CELLS AND TUMOR INFILTRATING IMMUNE CELLS
    Rider, Jennifer
    Harlow, Alyssa
    Giunchi, Francesca
    Carlsson, Jessica
    Kirrander, Peter
    Fiorentino, Michelangelo
    Andren, Ove
    Davidsson, Sabina
    [J]. JOURNAL OF UROLOGY, 2018, 199 (04): : E1129 - E1130
  • [33] Prognostic significance of PD-L2 expression in patients with oral squamous cell carcinoma-A comparison to the PD-L1 expression profile
    Weber, Manuel
    Wehrhan, Falk
    Baran, Christoph
    Agaimy, Abbas
    Buettner-Herold, Maike
    Kesting, Marco
    Ries, Jutta
    [J]. CANCER MEDICINE, 2019, 8 (03): : 1124 - 1134
  • [34] Tumor PD-L1 expression is associated with improved survival and lower recurrence risk in young women with oral cavity squamous cell carcinoma
    Hanna, G. J.
    Woo, S. -B.
    Li, Y. Y.
    Barletta, J. A.
    Hammerman, P. S.
    Loral, J. H.
    [J]. INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2018, 47 (05) : 568 - 577
  • [35] Expression of PD-L1 and p-RPS6 in epithelial dysplasia and squamous cell carcinoma of the oral cavity
    Hanroongsri, Jaruwat
    Amornphimoltham, Panomwat
    Younis, Rania H.
    Chaisuparat, Risa
    [J]. FRONTIERS IN ORAL HEALTH, 2024, 5
  • [36] Prognostic significance of tumour-infiltrating immune cells and PD-L1 expression in oesophageal squamous cell carcinoma in Chinese patients
    Jiang, Y.
    Lo, A. W. I.
    Wong, A.
    Chen, W.
    Sun, S.
    Lv, H.
    Xu, J.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S469 - S470
  • [37] PD-L1 expression in immune cells is a favorable prognostic factor for nasopharyngeal carcinoma
    Sahinli, Hayriye
    Akyurek, Nalan
    Yilmaz, Mukaddes
    Kandemir, Olcay
    Duran, Ayse Ocak
    Kulacoglu, Sezer
    Ucar, Gokhan
    Acar, Elif
    Ozet, Ahmet
    Gumus, Mahmut
    Oksuzoglu, O. Berna C.
    Ozdemir, Nuriye Y.
    [J]. INDIAN JOURNAL OF CANCER, 2021, 58 (04) : 561 - 566
  • [38] PROGNOSTIC UTILITY OF PD-L1 IN SQUAMOUS CELL CARCINOMA OF THE BLADDER
    Owyong, Michael
    Lotan, Yair
    Kapur, Payal
    Panwar, Vandana
    Lee, Thomas K.
    Zi, Xiaolin
    Martin, Jeremy W.
    Mosbah, Ahmed
    Abol-Enein, Hassan
    Ghoneim, Mohamed
    Youssef, Ramy F.
    [J]. JOURNAL OF UROLOGY, 2018, 199 (04): : E1039 - E1040
  • [39] Study of the PD-L1 expression, T-cells density and immunoscore in paired baseline tumor biopsies and surgical specimens in squamous cell carcinoma of the oral cavity
    Beyaert, Simon
    Borys, Alena
    Baldin, Pamela
    Dahou, Hajar
    Magremanne, Michele
    Mahy, Pierre
    Renwart, William
    Machiels, Jean -Pascal
    Schmitz, Sandra
    [J]. ORAL ONCOLOGY, 2024, 154
  • [40] Bacterial Lipopolysaccharide Induces PD-L1 Expression and an Invasive Phenotype of Oral Squamous Cell Carcinoma Cells
    Omori, Yuji
    Noguchi, Kazuma
    Kitamura, Mizuha
    Makihara, Yuna
    Omae, Takayuki
    Hanawa, Soutaro
    Yoshikawa, Kyohei
    Takaoka, Kazuki
    Kishimoto, Hiromitsu
    [J]. CANCERS, 2024, 16 (02)
12345